Marissa M Wen, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1507 Garden Farms Ave, Lathrop, CA 95330 Phone: 209-479-8000 |
News Archive
Novozymes Biopharma has entered a new collaboration with UK-based biotechnology company, ThioLogics. The collaboration brings together Novozymes' modified recombinant human albumin (rAlbumin) Veltis technology, with ThioLogics' site-specific next generation maleimide conjugation platform. This allows Novozymes to offer the pharma industry serum stable albumin drug conjugates with enhanced pharmacokinetic and/or targeting capabilities.
As the human body fine-tunes its neurological wiring, nerve cells often must fix a faulty connection by amputating an axon - the "business end" of the neuron that sends electrical impulses to tissues or other neurons. It is a dance with death, however, because the molecular poison the neuron deploys to sever an axon could, if uncontained, kill the entire cell.
Phase Forward, a leading provider of data management solutions for clinical trials and drug safety, today announced a contract award to support the FDA's production rollout of the company's WebSDMâ„¢ Release 3.0 software, including the Empiricaâ„¢ Study Clinical Trials Signal Detection system.
St. Jude Medical, Inc. today announced it has received European CE Mark approval for the industry's first quadripolar pacing system for cardiac resynchronization therapy defibrillators (CRT-Ds). The quadripolar system offers physicians the ability to more effectively and efficiently manage the ever-changing pacing needs of patients with heart failure.
Supposedly 'primitive' reflexes may involve more sophisticated brain function than previously thought, according to researchers at Imperial College London.
› Verified 6 days ago